(Q46738363)

24 December 2017

title

Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy (English)

1 reference

24 December 2017

0 references

M S Anil Kumar

1

1 reference

24 December 2017

S Khan

2

1 reference

24 December 2017

K Ranganna

3

1 reference

24 December 2017

G Malat

4

1 reference

24 December 2017

N Sustento-Reodica

5

1 reference

24 December 2017

W C Meyers

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

24 December 2017

American Journal of Transplantation

published in

1 reference

24 December 2017

volume

8

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

574-585

1 reference

24 December 2017

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Long-term immunosuppression, without maintenance prednisone, after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Short-term experience with early steroid withdrawal in African-American renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Natural history, risk factors, and impact of subclinical rejection in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

The significance of subclinical rejection and the value of protocol biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02099.X

10.1111/J.1600-6143.2007.02099.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017